News - Sexually related disorders
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 





DateSubject
01/12/2010 05:42:29 PM
Switching HIV-Infected Patients to Raltegravir Improves Lipids, But With Lower Virological Control
01/07/2010 07:08:11 PM
Study Finds Increased Presence, Severity of Coronary Artery Plaques in HIV-Positive Men
11/20/2009 09:16:50 AM
ACOG Recommends Pap Tests Begin Later, Be Repeated Less Frequently
11/01/2009 11:19:42 AM
New Vaccine for Human Papillomavirus 16/18 Shows High Levels of Immunogenicity: Presented at IDSA
10/20/2009 05:21:23 PM
Combination HIV Vaccine Regimen Demonstrates Modest Efficacy
09/09/2009 06:33:47 PM
Trichomonas Vaginalis Linked to Increased Risk of Aggressive Prostate Cancer
08/31/2009 04:11:22 PM
HIV Subtype D Linked to Increased Likelihood for Dementia
08/17/2009 11:55:02 AM
Updated HIV Guidelines Emphasise Primary Care Need of Patients
07/24/2009 05:24:01 PM
Study Identifies Distinct Characteristics of Patients Presenting With Late Stage HIV: Presented at IAS
07/23/2009 06:18:57 PM
Once-Daily Darunavir/Ritonavir Monotherapy as Effective as Standard HAART: Presented at IAS
07/23/2009 06:13:51 PM
Simplified HIV Regimen Without Ritonavir Effective in HIV Patients With Suppressed Viral Loads: Presented at IAS
07/23/2009 06:12:08 PM
No Link Found Between Abacavir and Cardiovascular Disease Biomarkers: Presented at IAS
07/23/2009 05:50:34 PM
Abacavir Does Not Appear to Increase MI, Stroke Risk in Most HIV-Positive Patients: Presented at IAS
07/23/2009 05:22:18 PM
Once-Daily Lopinavir/Ritonavir as Effective as Twice Daily Dosing in Treatment-Experienced HIV Patients: Presented at IAS
07/22/2009 06:21:36 PM
Once-Daily Lopinavir/Ritonavir Tablets Show Similar, Durable Efficacy as Twice-Daily Dosing: Presented at IAS
07/21/2009 04:04:31 PM
Most Patients With NNRTI Resistance Maintain Susceptibility to Etravirine: Presented at IAS
07/20/2009 06:21:05 PM
Raltegravir Maintains Efficacy Versus Efavirenz After 144 Weeks: Presented at IAS
07/20/2009 05:47:06 PM
Nevirapine Equally Effective, Improves Lipids Compared With Atazanavir in HIV: Presented at IAS
07/20/2009 05:32:33 PM
Etravirine Offers Durable Virologic Efficacy in Patients Resistant to NNRTIs and PIs: Presented at IAS
06/22/2009 05:49:06 PM
Use of Assay Can Detect Lower Genital Tract Infections in Patients With Neisseria gonorrhoeae: Presented at ICC
06/01/2009 01:49:55 PM
HPV Vaccine Effective in Women Aged 24 to 45 Years Not Already Infected With the Virus
05/31/2009 08:50:47 PM
Tumour HPV Status Predicts Survival in Patients With Oropharynx Cancers: Presented at ASCO
05/16/2009 02:30:57 PM
Smoking Is Independent Risk Factor for Cervical Cancer in Women With Oncogenic HPV Types: Presented at IPV
05/15/2009 06:20:44 PM
Two-Dose Paediatric Regimen of Quadrivalent HPV Vaccine for Preadolescent Girls as Effective as 3 Doses: Presented at IPV
05/15/2009 05:49:54 PM
Quadrivalent HPV Vaccine Reduces Persistent Anogenital HPV Infection in Men Who Have Sex With Men: Presented at IPV
05/15/2009 05:33:25 PM
Bivalent HPV Vaccine Shows Efficacy Against Cervical Intraepithelial Neoplasia: Presented at IPV
05/15/2009 05:24:13 PM
Immunogenicity of Quadrivalent HPV Vaccine in Men Comparable to That of Women: Presented at IPV
12/03/2008 01:30:35 PM
European Union Approves Darunavir for Treatment-Experienced Patients
11/14/2008 12:19:36 PM
Percutaneous Coronary Intervention Safe in Patients Infected With HIV: Presented at AHA
11/01/2008 12:47:02 PM
Herpes Often Spread Unknowingly by Young Women: Presented at ICAAC/ISDA
10/30/2008 10:58:27 AM
Long-Term Results With Vicriviroc Show Decreasing Evidence of Malignancy: Presented at ICAAC/IDSA
10/30/2008 09:35:41 AM
Atazanavir/Ritonavir Noninferior to Lopinavir/Ritonavir Over 96 Weeks in Treatment-Naïve HIV Patients: Presented at ICAAC/IDSA
10/28/2008 02:49:30 PM
Darunavir/Ritonavir Achieves Superiority Over Lopinavir/Ritonavir in Suppressing Human Immunodeficiency Virus: Presented at ICAAC/IDSA
10/14/2008 02:54:43 PM
Efavirenz-Based Therapies Associated With Better Outcomes in HIV Patients in Developing Countries
08/10/2008 08:23:25 PM
HIV Patients Resistant to Non-Nucleoside Reverse Transcriptase Inhibitors Experience Superior Results With Etravirine: Presented at AIDS 2008
08/10/2008 08:18:47 PM
Outcome Data Disputed in Abacavir/Lamivudine Comparison Trial: Presented at AIDS 2008
08/09/2008 08:06:48 AM
HIV Patients With High Viral Load Worsen on Fixed-Dose Abacavir/Lamivudine Compared With Fixed-Dose Tenofovir/Emtricitabine: Presented at AIDS 2008
08/08/2008 07:02:26 PM
Combination of 3 New HIV Drugs Drives Virus to Undetectable Levels in Treatment-Experienced Patients: Presented at AIDS 2008
08/08/2008 05:28:28 PM
Abacavir Linked to Heart Disease in Patients With HIV: Presented at AIDS 2008
07/24/2008 03:07:16 PM
Contaminated Nelfinavir Does Not Increase Cancer Risk, EMEA Concludes
07/24/2008 10:22:31 AM
Extended-Dose Nevirapine May Reduce Risk of Mother-to-Infant HIV Transmission in Developing Countries
07/22/2008 05:05:21 PM
New Noninvasive Methods Identified for Detecting Human Papillomavirus: Presented at AHNS
07/22/2008 12:11:13 PM
Presence of Human Papillomavirus Infection Has No Prognostic Value in Tongue Cancer Patients: Presented at AHNS
07/18/2008 02:35:20 PM
HIV Conquers Immune System Faster Than Previously Realised
06/20/2008 08:52:43 AM
Aciclovir Does Not Reduce HIV Acquisition in Women or Gay Men With Genital Herpes
04/24/2008 10:26:27 AM
Seven-Day Doxycycline Superior to Single-Dose Azithromycin in Men With C Trachomatis Urethritis: Presented at ECCMID
03/27/2008 04:18:01 PM
US FDA Issues Update of Ongoing HIV Drug Safety Review
02/11/2008 09:12:42 AM
Delay in Treatment Modification After Non-Protease Inhibitor Therapy Failure Increases Risk of HIV Progression: Presented at CROI
02/11/2008 09:07:22 AM
Higher Risk of Death for Treatment-Naive HIV Patients With High CD4-Positive Cell Counts: Presented at CROI
02/08/2008 04:00:25 PM
Growth Hormone Replacement Reduces Obesity and Improves Diastolic Blood Pressure in Patients With HIV: Presented at CROI
02/08/2008 12:30:10 PM
Boosted Interferon Achieves Sustained Virologic Response With Reduced Liver Complications in Patients With HIV/Hepatitis C: Presented at CROI
02/07/2008 03:13:48 PM
IL-2 Fails to Boost CD4 Cells, But T-20 Proves Effective in Severely Immunocompromised HIV Patients: Presented at CROI
02/07/2008 02:31:52 PM
Investigational Amdoxovir Plus Zidovudine Rapidly Reduces HIV Levels in Preliminary Test: Presented at CROI
02/07/2008 02:30:17 PM
Double-Boosted Saquinavir/Lopinavir Combination Safe and Effective for Treatment-Resistant Children With AIDS: Presented at CROI
02/07/2008 02:25:15 PM
Trial Results Show Etravirine Safe and Effective in HIV-1 for Treatment-Resistant Patients: Presented at CROI
02/07/2008 08:46:42 AM
Nelfinavir Acts in HIV-Infected Neonates as in Adults, But Individual Drug Monitoring Still Required: Presented at CROI
02/07/2008 07:19:22 AM
Enfuvirtide Appears Safe, Prevents Transmission of HIV to Newborns in Emergent Cases: Presented at CROI
02/06/2008 05:37:35 PM
Switching From Zidovudine- to Tenofovir-Based Therapy Preserves and Recovers Limb Fat in Patients With Human Immunodeficiency Virus: Presented at CROI
02/06/2008 05:13:41 PM
Raltegravir Maintains Suppression of HIV Virus in Treatment-Experienced Patients Up to 48 Weeks: Presented at CROI
02/06/2008 04:10:15 PM
Maraviroc-Based Antiretroviral Treatment Appears Neutral in Effects on HIV Patient Lipids: Presented at CROI
02/06/2008 03:09:05 PM
Low Risk of Hepatotoxicity With Once-Daily Nevirapine: Presented at CROI
02/06/2008 12:55:39 PM
Patients at High Risk of Heart Disease Fare Poorly While Taking Abacavir or Didanosine: Presented at CROI
02/06/2008 09:04:36 AM
Once-Daily Boosted Atazanavir as Effective as Twice-Daily Boosted Lopinavir in Treatment-Naive HIV Patients: Presented at CROI
02/06/2008 09:02:17 AM
Abacavir/Lamivudine Noninferior to Tenofovir/Emtricitabine as Backbone to Lopinavir/Ritonavir HIV Therapy: Presented at CROI
02/06/2008 08:46:56 AM
Tesamorelin Helps Improve Body Composition in HIV Patients at Increased Cardiovascular Risk: Presented at CROI
02/05/2008 05:25:27 PM
Once-Daily Darunavir Sufficient to Suppress HIV in Treatment-Naive Patients: Presented at CROI
02/05/2008 05:20:25 PM
Boosted Lopinavir Safe and Tolerable in Once-Daily Dosing and in Tablet Formulation: Presented at CROI
02/05/2008 05:16:43 PM
Patients Who Resume Therapy After Treatment Interruption Regain Some But Not All Effectiveness Against HIV: Presented at CROI
02/04/2008 02:18:47 PM
New CCR5 Antagonist SCH532706 Shows Long Half-Life: Presented at CROI
02/04/2008 12:53:49 PM
Addition of Vicriviroc Allows Treatment-Experienced Patients to Achieve Undetectable HIV Levels: Presented at CROI
11/20/2007 08:09:18 AM
Use of Intraoperative MRI Adds Time but Care-Changing Information to Neurosurgery
11/09/2007 02:00:43 PM
Study Finds Strong Demand for HIV Meds After High-Risk Sex
09/21/2007 04:09:03 PM
Axcil and Desirin Dietary Supplements Recalled Because They Were Found to Contain Potentially Harmful Ingredients
09/11/2007 05:11:36 PM
New HIV Diagnoses Rising in New York City Among Young Men Who Have Sex With Men
09/11/2007 11:05:29 AM
Tadalafil Appears Helpful for Treatment of Erectile Dysfunction in Men With Spinal Cord Injuries
03/08/2006 01:15:33 PM
Famciclovir (Famvir) Improves Time-to-Healing in Genital Herpes Outbeak: Presented at AAD
05/02/2005 09:43:44 AM
Investigational Vaccine Against Human Papillomavirus Appears to Reduce Infection and Related Diseases
04/06/2005 12:15:39 PM
Hormonal Birth Control, Bacterial Infections in Women Linked to Increased Shedding of Herpes Simplex Virus Type 2
01/19/2005 02:40:04 PM
Male Circumcision Reduces Risk of HIV Transmission From Women to Men
10/08/2004 12:43:46 PM
IDSA: Tinidazole Effective and Well-Tolerated Against Metronidazole-Resistant Trichomoniasis
10/08/2004 09:09:39 AM
IDSA: Patient-Collected Swabs as Efficient as Clinician-Collected Swabs in Screening for Chlamydia Trachomatis
07/29/2004 09:29:25 AM
Condom Use Decreases Pelvic Inflammatory Disease Recurrence
05/17/2003 10:30:08 AM
AGS: Vardenafil Improves Sexual Function Regardless of Age
10/01/2002 10:30:38 AM
ICAAC: Emtricitabine Superior to Stavudine for HIV Infection
09/30/2002 01:21:14 PM
ICAAC: Once-a-Day Dosing for HIV Equivalent to Twice-a-Day Regimens
09/30/2002 11:26:06 AM
ICAAC: New Protease Inhibitor Outperforms Nelfinavir in Achieving Undetectable HIV Viral Loads
09/30/2002 11:13:52 AM
ICAAC: Valacyclovir prevents transmission of sexually transmitted genital herpes
07/12/2002 03:54:39 PM
AIDS 2002: Extra Spermicidal Lubricant Reduces Condom Failures, Improves Pleasure
06/28/2002 02:22:12 PM
CINP: Extended Release Gepirone May Improve Sexual Function in Depressive Patients
06/28/2002 11:24:45 AM
CINP: Antipsychotic-related Sexual Dysfunction Leads to Nonadherence in Patients with Schizophrenia
04/19/2002 11:25:24 AM
AAN: Viagra (Sildenafil) Effective for Erectile Dysfunction in Men with Multiple Sclerosis
03/19/2002 03:45:09 PM
Women With Genital Warts Should Be Closely Monitored For Vaginal And Other Anogenital Cancers
02/26/2002 09:53:48 AM
EAU: Vardenafil Improves Erectile Function Following Radical Prostatectomy
12/12/2001 12:39:43 PM
Aldara (Imiquimod) Safe, Effective For Treatment of External Genital Warts
10/17/2001
ACEP: Vaginitis Often Missed Because Classic Findings Are Absent
10/16/2001
Human Immunodeficiency Virus (HIV) Can Be Transmitted to Others Within Days of Infection
09/05/2001
IPC: Trial Supports Human Papillomavirus Testing As Primary Cervical Cancer Screen
08/14/2001
NHPC 2001 -- Some Doctors Still Fail To Counsel HIV-Infected Patients On Safe Sex
08/01/2001
Counseling Improves Safe-Sex Practices In Individuals with Human Immunodeficiency Virus
07/17/2001
FDA Approves Valtrex (Valacyclovir) Change From Five Days to Three for Genital Herpes
06/20/2001

[Next Page]